<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Unlocking the Potential of Autologous Cell &amp;amp; Gene Therapy Through Digital Transformation</title><link>/industries/lifesciences/b/life-sciences-blog/posts/unlocking-the-potential-of-autologous-cell-gene-therapy-through-digital-transformation</link><description>Autologous and personalised cell and gene therapies (CGTs) represent one of the most promising frontiers in modern medicine offering curative potential for conditions once deemed untreatable. However, realising their full potential at scale remains a</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>